173 filings
Page 6 of 9
UPLOAD
twobb e0wv
10 Feb 21
Letter from SEC
12:00am
8-K
kq75om00y bv
12 Jan 21
AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results
10:50am
8-K
s39nkourpyl0 fm4b51k
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
3:33pm
8-K
q2w1lz2ya5bj
2 Dec 20
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
11:01am
S-8
zaku5d0wyl922ru3e
24 Nov 20
Registration of securities for employees
2:59pm
8-K
butnjqwc z0
12 Nov 20
Submission of Matters to a Vote of Security Holders
10:05am
10-Q
tt0z9k26e89aprr8wy
10 Nov 20
Quarterly report
4:11pm
8-K
p8dg 9a103
10 Nov 20
Other Events
10:45am
8-K
58w 4lpbrcq
6 Nov 20
AVITA Therapeutics, Inc. Announces Executive Change
6:06am
8-K
6nxvkq7f 182
4 Nov 20
Avita Therapeutics, Inc. Announces Correction of Time for the 2020 Annual Stockholder Meeting
10:00pm
DEFA14A
p0204a5 2wz0dp7a
4 Nov 20
Additional proxy soliciting materials
9:58pm
8-K
j3dfbijnxy7dqq
2 Nov 20
AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder Meeting
10:04am
DEFA14A
g4abfv7d5uea6k5azc
2 Nov 20
Additional proxy soliciting materials
10:02am
EFFECT
v6z5qw mu5dbj
19 Oct 20
Notice of effectiveness
12:15am
UPLOAD
fd00uvverk359 9z270f
15 Oct 20
Letter from SEC
12:00am
CORRESP
vr734 hxh
15 Oct 20
Correspondence with SEC
12:00am
8-K
sa7s7q 9obls50991a9
13 Oct 20
Shelf Registration Statement Filed with SEC
10:36am
S-3
dt1h8 j9q3d1a3z5
9 Oct 20
Shelf registration
4:47pm
DEF 14A
i77ukt6j47z2v zbr
25 Sep 20
Definitive proxy
12:28pm
PRE 14A
ou7giix
14 Sep 20
Preliminary proxy
5:19pm